Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
  1. 4 Open-market sale Felsch Robert Ora sold 1,048 shares at $3.55 ($3,722)
  2. 4 Open-market sale Blanks Robert sold 2,846 shares at $3.55 ($10,108)
  3. 4 Open-market sale Chief Medical Officer sold 25,000 shares at $3.35 ($83,633)
  4. 4 Planned sale Blanks Robert sold 33,333 shares at $3.63 ($121,042)
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award Director acquired 12,755 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Grant or award Director acquired 12,755 shares (grant or award)
  9. 4 Grant or award Director acquired 18,494 shares (grant or award)
  10. 4 Grant or award Director acquired 16,581 shares (grant or award)
  11. 4 Grant or award Director acquired 25,510 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale Felsch Robert Ora sold 1,046 shares at $3.65 ($3,821)
  14. 4 Open-market sale President & CEO sold 11,357 shares at $3.65 ($41,489)
  15. 4 Open-market sale GRAMMER ELIZABETH A sold 2,384 shares at $3.65 ($8,709)
  16. 4 Open-market sale Blanks Robert sold 2,835 shares at $3.65 ($10,357)
  17. 4 Open-market sale Chief Financial Officer sold 2,873 shares at $3.65 ($10,496)
  18. 4 Open-market sale Chief Commercial Officer sold 4,711 shares at $3.65 ($17,210)
  19. 4 Open-market sale Chief Development Officer sold 3,769 shares at $3.65 ($13,769)
  20. 4 Open-market sale Chief Medical Officer sold 2,583 shares at $3.65 ($9,436)

Page 12 of 35 · 696 filings